Randomized phase II trial of daily administration versus alternate-day administration of S-1 in patients with advanced non-small cell lung cancer

Aya Suzuki, Makoto Maemondo, Shunichi Sugawara, Taku Nakagawa, Kageaki Taima, Akira Inoue, Kazuhiko Matsuno, Kazuhiro Usui, Takashi Yokoi, Mariko Kanbe, Toshihiro Nukiwa

Research output: Contribution to journalArticlepeer-review

1 Citation (Scopus)

Fingerprint

Dive into the research topics of 'Randomized phase II trial of daily administration versus alternate-day administration of S-1 in patients with advanced non-small cell lung cancer'. Together they form a unique fingerprint.

Medicine & Life Sciences